Long-Term Air Pollution Exposure and Severity of Idiopathic Pulmonary Fibrosis Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry

被引:0
|
作者
Sack, Coralynn [1 ]
Wojdyla, Daniel M. [2 ]
Macmurdo, Maeve G. [3 ]
Gassett, Amanda [1 ]
Kaufman, Joel D. [1 ]
Raghu, Ganesh [1 ]
Redlich, Carrie A. [4 ]
Li, Peide [5 ]
Olson, Amy L. [5 ]
Leonard, Thomas B. [5 ]
Todd, Jamie L. [2 ,6 ]
Neely, Megan L. [2 ,6 ]
Snyder, Laurie D. [2 ,6 ]
Gulati, Mridu [4 ]
机构
[1] Univ Washington, 303 Roosevelt One Bldg,4225 Roosevelt Way NE, Seattle, WA 98105 USA
[2] Duke Clin Res Inst, Durham, NC USA
[3] Cleveland Clin, Cleveland, OH USA
[4] Yale Sch Med, New Haven, CT USA
[5] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA
[6] Duke Univ, Med Ctr, Durham, NC USA
关键词
interstitial lung diseases; pulmonary fibrosis; pollution; ACUTE EXACERBATION; ASSOCIATION; DIAGNOSIS; SURVIVAL;
D O I
10.1513/AnnalsATS.202404-382OC
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Rationale: Although exposure to air pollution is a known risk factor for adverse pulmonary outcomes, its impact in individuals with idiopathic pulmonary fibrosis (IPF) is less well understood. Objectives: To investigate the effects of long-term exposure to air pollution on disease severity and progression in patients with IPF and to determine whether genomic factors, such as MUC5B promoter polymorphism or telomere length, modify these associations. Methods: We performed analyses at enrollment and after 1 year of follow-up in the IPF-PRO (Idiopathic Pulmonary Fibrosis Prospective Outcomes) Registry, a prospective observational registry that enrolled individuals with IPF at 46 U.S. sites from June 2014 to October 2018. Five-year average pollution exposures (particulate matter <= 2.5 mu m in aerodynamic diameter [PM2.5], nitrogen dioxide, ozone) before the enrollment date were estimated at participants' residential addresses with validated national spatiotemporal models. Multivariable regression models estimated associations between pollution exposure and physiologic measurements (forced vital capacity [FVC], diffusing capacity of the lung for carbon monoxide, supplemental oxygen use at rest) and quality-of-life measurements (St. George's Respiratory Questionnaire, EuroQoL, Cough and Sputum Assessment Questionnaire) at enrollment. Cox proportional hazards models estimated associations between pollutants and a composite outcome of death, lung transplant, or >10% absolute decline in FVC percent predicted in the year after enrollment. Models were adjusted for individual-level and spatial confounders, including proxies for disease onset. Gene-environment interactions with MUC5B and telomere length were assessed. Results: Of 835 participants, 94% were non-Hispanic White individuals, 76% were male, and the mean (standard deviation) age was 70 (7.7) years. In fully adjusted analyses, higher PM2.5 exposure was associated with worse quality of life per St. George's Respiratory Questionnaire activity score (3.48 [95% confidence interval (CI), 0.64, 6.32] per 2 mu g/m(3) PM2.5) and EuroQoL scores (-0.04 [95% CI, -0.06, -0.01] per 2 mu g/m(3) PM2.5), as well as lower FVC percent predicted and lower diffusing capacity of the lung for carbon monoxide percent predicted at enrollment(.) Each 3 parts per billion difference in O-3 exposure was associated with a 1.57% (95% CI, 0.15, 2.98) higher FVC percent predicted at enrollment, although this effect was attenuated in multipollutant models. There was no association between nitrogen dioxide and enrollment measures or between pollution exposure and 1-year outcomes and no evidence for gene-environment interactions. Conclusions: In the IPF-PRO Registry, long-term exposure to PM2.5 was associated with worse quality of life and lung function at enrollment, but not with short-term disease progression or mortality. There was no evidence of effect modification by interaction of genomic factors with pollution. The reason for the unexpected relationship between O-3 exposure and higher FVC is unclear.
引用
收藏
页码:378 / 386
页数:9
相关论文
共 50 条
  • [41] Disease Severity and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis A Cross-Sectional Analysis of the IPF-PRO Registry
    O'Brien, Emily C.
    Hellkamp, Anne S.
    Neely, Megan L.
    Swaminathan, Aparna
    Bender, Shaun
    Snyder, Laurie D.
    Culver, Daniel A.
    Conoscenti, Craig S.
    Todd, Jamie L.
    Palmer, Scott M.
    Leonard, Thomas B.
    CHEST, 2020, 157 (05) : 1188 - 1198
  • [42] LONG-TERM NINTEDANIB TREATMENT IN IDIOPATHIC PULMONARY FIBROSIS (IPF)
    Song, Jin Woo
    Quaresma, Manuel
    Kaye, Mitchell
    Stansen, Wibke
    Stowasser, Susanne
    Kreuter, Michael
    RESPIROLOGY, 2017, 22 : 46 - 46
  • [43] Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry
    Snyder, Laurie
    Neely, Megan L.
    Hellkamp, Anne S.
    O'Brien, Emily
    de Andrade, Joao
    Conoscenti, Craig S.
    Leonard, Thomas
    Bender, Shaun
    Gulati, Mridu
    Culver, Daniel A.
    Kaner, Robert J.
    Palmer, Scott
    Kim, Hyun Joo
    Asi, Wael
    Baker, Albert
    Beegle, Scott
    Belperio, John A.
    Condos, Rany
    Cordova, Francis
    Dilling, Daniel
    Flaherty, Kevin
    Glassberg, Marilyn
    Guntupalli, Kalpalatha
    Gupta, Nishant
    Case, Amy Hajari
    Hotchkin, David
    Huie, Tristan
    Kaner, Robert
    Kim, Hyun
    Kreider, Maryl
    Lancaster, Lisa
    Lasky, Joseph
    Lederer, David
    Lee, Doug
    Liesching, Timothy
    Lipchik, Randolph
    Lobo, Jason
    Mageto, Yolanda
    Menon, Prema
    Morrison, Lake
    Namen, Andrew
    Oldham, Justin
    Raj, Rishi
    Ramaswamy, Murali
    Russell, Tonya
    Sachs, Paul
    Safdar, Zeenat
    Sigal, Barry
    Silhan, Leann
    Strek, Mary
    RESPIRATORY RESEARCH, 2019, 20
  • [44] Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry
    Laurie Snyder
    Megan L. Neely
    Anne S. Hellkamp
    Emily O’Brien
    Joao de Andrade
    Craig S. Conoscenti
    Thomas Leonard
    Shaun Bender
    Mridu Gulati
    Daniel A. Culver
    Robert J. Kaner
    Scott Palmer
    Hyun Joo Kim
    Respiratory Research, 20
  • [45] Long-term personal air pollution exposure and risk for acute exacerbation of idiopathic pulmonary fibrosis
    Tomos, Ioannis
    Dimakopoulou, Konstantina
    Manali, Effrosyni D.
    Papiris, Spyros A.
    Karakatsani, Anna
    ENVIRONMENTAL HEALTH, 2021, 20 (01)
  • [46] Long-term personal air pollution exposure and risk for acute exacerbation of idiopathic pulmonary fibrosis
    Ioannis Tomos
    Konstantina Dimakopoulou
    Effrosyni D. Manali
    Spyros A. Papiris
    Anna Karakatsani
    Environmental Health, 20
  • [47] Associations of circulating matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases with clinically relevant outcomes in idiopathic pulmonary fibrosis: Data from the IPF-PRO Registry
    Amubieya, Olawale
    Todd, Jamie L.
    Neely, Megan L.
    Kaner, Robert J.
    Lasky, Joseph A.
    Namen, Andrew
    Hesslinger, Christian
    Palmer, Scott M.
    Weigt, S. Samuel
    Belperio, John A.
    PLOS ONE, 2024, 19 (10):
  • [48] A Multivariable Protein-Inclusive Predictor of Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis: Data from the IPF-PRO Registry
    Todd, J. L.
    Neely, M. L.
    Mulder, H.
    Lancaster, L. H.
    White, E. S.
    Hesslinger, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [49] Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort
    Jamie L. Todd
    Megan L. Neely
    Robert Overton
    Hillary Mulder
    Jesse Roman
    Joseph A. Lasky
    Joao A. de Andrade
    Mridu Gulati
    Howard Huang
    Thomas B. Leonard
    Christian Hesslinger
    Imre Noth
    John A. Belperio
    Kevin R. Flaherty
    Scott M. Palmer
    Lung, 2022, 200 : 11 - 18
  • [50] Long-Term Personal Exposure to Air Pollution and Risk for Acute Exacerbation of Idiopathic Pulmonary Fibrosis, in Greece
    Tomos, I.
    Dimakopoulou, K.
    Manali, E.
    Karakatsani, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)